Targeting cancer metabolism has emerged as a promising therapeutic approach, particularly in the context of novel drug discovery. Metabolic alterations in cancer cells support their growth, survival, and resistance to treatment. Researchers are investigating how metabolic pathways, such as those involved in glucose uptake, fatty acid oxidation, and amino acid metabolism, can be modulated to disrupt cancer cell function. Targeting metabolic enzymes or signaling pathways could sensitize tumors to chemotherapy, immunotherapy, or radiation, potentially overcoming resistance mechanisms. By identifying specific metabolic vulnerabilities in cancer cells, researchers hope to design more effective and less toxic therapies that selectively target the altered metabolism of cancer cells, offering hope for patients with hard-to-treat cancers.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States